Cost-Effectiveness of Second-Generation Antipsychotics and Perphenazine in a Randomized Trial of Treatment for Chronic Schizophrenia

Retired Professor and Chairman, Department of Psychiatry and Behavioral Sciences; Director, Institute of Psychiatry, Medical University of South Carolina; Private Practice, Charleston, South Carolina